Affluense AI AFFLUENSE

Healthcare Portfolio

InCred Asset Management
PMS Thematic
Benchmark
S&P BSE 500 TRI
Inception Date
15 February 2021
Min. Investment
₹50,00,000
SIP Available
No
STP Available
No

Investment Strategy

Investment Approach

The investment strategy will involve a judicious selection of equities across large, mid, and small-cap segments. Investment decisions will be guided by in-depth fundamental analysis, encompassing both qualitative and quantitative assessments of potential holdings.

Investment Objective

The investment strategy centers on allocating capital to equity and equity-linked securities, with a principal emphasis on companies operating within India's healthcare sector.

Performance Returns

Returns as on 2025-12-31

Trailing Returns

Period Strategy Benchmark Outperformance
1 MONTH -4.31% -0.24% -4.07%
3 MONTHS 3.27% 5.02% -1.75%
6 MONTHS 9.98% 1.63% 8.35%
1 YEAR 12.47% 7.63% 4.84%
2 YEAR 26.69% 11.64% 15.05%
3 YEAR 30.96% 16.40% 14.56%
SINCE INCEPTION 20.37% 15.27% 5.10%

Calendar Year Performance

Year Return
CY 2025 12.47%
CY 2024 42.75%
CY 2023 39.92%
CY 2022 -6.07%
CY 2021 17.97%

Financial Year Performance

Year Return
FY 26_YTD 19.83%
FY 25 36.88%
FY 24 50.18%
FY 23 -5.01%
FY 22 7.15%
FY 21 -0.99%

Past performance is not indicative of future results. Returns are subject to market risks.

Fund Managers

Aditya Khemka

Fund Manager

Mr. Aditya Khemka possesses 18 years of extensive experience in the healthcare sector, encompassing both business operations and investment activities. His global exposure spans the United States, European Union, Latin America, and India. Academically, he holds an MSc. in Finance, a Post Graduate Diploma in Management from MDI Gurgaon, and professional certifications including CIIA (UK) and CFA from ICFAI. During his tenure at DSP, he was instrumental in developing and implementing a product strategy that consistently outperformed its benchmark by generating alpha within an 18-month timeframe. This strategy was further characterized by low customer attrition and a superior Sharpe ratio when compared to industry peers.

Portfolio Details

Portfolio Composition

Large Cap
0.00%
Mid Cap
5.60%
Small Cap
92.06%
Cash & Equivalent
2.30%

Top 5 Holdings

  • Healthcare Global Enterprises Limited 15.02%
  • Jubilant Pharmova Limited 10.00%
  • Krsnaa Diagnostics Limited 9.99%
  • Thyrocare Technologies Limited 9.83%
  • Artemis Medicare Services Limited 8.00%

Top 5 Sectors

  • Healthcare 97.66%

Portfolio Characteristics

total number of stocks
15
top 5 stocks percent
52.84%
top 5 sectors percent
97.66%
average market cap
22000
portfolio age
4 Yrs, 10 Months
sip
Not Available
stp
Not Available

Fee Structure

Fixed Fee

AMC: 2.5%

Variable Fee

AMC: 1.5%

Hurdle: 8%

Profit Sharing: 20%

Exit Load

Year 1: 2%

Year 2: 1%

Year 3: 0%

Interested in ?

Get in touch with our partner to learn more about 's portfolio management services and how they align with your investment goals.

Disclaimer

Returns are as of 2025-12-31. Returns for periods up to one year are not annualized. Returns for periods exceeding one year are annualized. Returns are computed using the Time Weighted Rate of Return (TWRR) methodology and are provided by the respective Asset Management Companies (AMCs). 'ND' denotes 'No Data', and 'NA' denotes 'Not Applicable'. The performance of the respective Benchmark Indices is presented above. Benchmark(s) are as defined in SEBI circular no. SEBI/HO/IMD/IMD-PoD-2/P/CIR/2022/172 dated December 16, 2022, APMI circular no. APMI/2022-23/02 dated March 23, 2023, and Revised Annexure-1.

This page is provided solely for general informational purposes in relation to the strategy and is based on publicly available information. While reasonable care has been taken to ensure accuracy, the information may not reflect the most recent updates.

Nothing on this page constitutes investment, financial, or legal advice. Investment decisions should be made after consulting a qualified advisor and reviewing official scheme documents.

Last Updated: January 2026 · Published by Affluense AI (affluense.ai)